{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:02:03Z","timestamp":1789560123628,"version":"build-2803163510"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To estimate the optimal duration of postpartum magnesium sulphate to prevent eclampsia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>MEDLINE, EMBASE, CINAHL, the Cochrane Database of Systematic Reviews, and ClinicalTrials.gov databases were searched from inception until January 2020 and limited to English-language human randomized controlled trials. Search strategy included the key works \u201ceclampsia,\u201d \u201cmagnesium sulphate,\u201d and \u201cpostpartum.\u201d<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS OF STUDY SELECTION:<\/jats:title>\n                    <jats:p>Title, abstract, and full-text review was performed using Covidence data-management software. Of the 3,629 articles screened, 10 studies were included in the final review. Studies were included if they compared two different time points of magnesium sulphate postpartum in women with either preeclampsia or eclampsia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TABULATION, INTEGRATION AND RESULTS:<\/jats:title>\n                    <jats:p>\n                      Two authors reviewed studies independently. RevMan software was used to calculate risk difference (RD) for categorical outcomes and mean difference for continuous outcomes. Shorter duration of magnesium sulphate (12 hours or less) was not associated with increased risk of eclampsia compared with 24-hour postpartum regimens (RD \u22120.01, 95% CI \u22120.02 to 0.01, I\n                      <jats:sup>2<\/jats:sup>\n                      70%). Studies randomizing women with preeclampsia did not show increased risk of eclampsia with shorter regimens (RD 0, 95% CI \u22120.01 to 0.01, I\n                      <jats:sup>2<\/jats:sup>\n                      0%), nor did trials randomizing those with eclampsia (RD \u22120.04, 95% CI \u22120.14 to 0.07, I\n                      <jats:sup>2<\/jats:sup>\n                      87%). Secondary outcomes, including flushing, duration of Foley catheter insertion, time to ambulation, and duration of hospital stay, were all reduced with shorter-duration magnesium sulphate.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>This systematic review and meta-analysis suggests that a shorter duration of postpartum magnesium sulphate does not increase the risk for eclamptic seizure; however, data remain underpowered to render firm conclusions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SYSTEMATIC REVIEW REGISTRATION:<\/jats:title>\n                    <jats:p>PROSPERO, CRD42020182432.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000004720","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T17:08:04Z","timestamp":1646932084000},"page":"521-528","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Duration of Postpartum Magnesium Sulphate for the Prevention of Eclampsia"],"prefix":"10.1097","volume":"139","author":[{"given":"Maureen","family":"Okonkwo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1701-2163(15)30588-0","article-title":"Diagnosis, evaluation and management of the hypertensive disorders of pregnancy: executive summary","volume":"36","author":"Magee","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.ajog.2003.12.057","article-title":"Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials","volume":"190","author":"Sibai","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","article-title":"Do women with preeclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial","volume":"359","author":"Altman","year":"2002","journal-title":"Lancet"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/01.AOG.0000236493.35347.d8","article-title":"Abbreviated postpartum magnesium sulfate therapy in women with mild preeclampsia","volume":"108","author":"Ehrenberg","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.3109\/14767058.2015.1083547","article-title":"A comparison between the two methods of magnesium sulfate administration for duration of 12 versus 24 h after delivery in patients with severe preeclampsia","volume":"29","author":"Kashanian","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00404-015-3903-y","article-title":"Short-course postpartum (6hr) magnesium sulfate therapy in severe preeclampsia","volume":"293","author":"Anjum","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijgo.2011.09.028","article-title":"A shortened postpartum magnesium sulfate prophylaxis regime in pre-eclamptic women at low risk of eclampsia","volume":"116","author":"Darngawn","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/14767058.2014.991915","article-title":"A novel protocol for postpartum magnesium sulphate in severe preeclampsia: a randomized controlled pilot trial","volume":"29","author":"El-Khayat","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R12-20260916","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijgo.2014.03.024","article-title":"Abbreviated (12-hour) versus traditional (24-hour) postpartum magnesium sulfate therapy in severe preeclampsia","volume":"126","author":"Maia","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12884-017-1424-3","article-title":"Magnesium sulfate for 6 vs 24 hours post delivery in patients who received magnesium sulfate for less than 8 hours before birth: a randomized clinical trial","volume":"17","author":"Vigil-DeGracia","year":"2017","journal-title":"BMC Pregnancy and Childbirth"},{"key":"R14-20260916","first-page":"131","article-title":"A shortened versus standard matched postpartum magnesium sulphate regimen in the treatment of eclampsia: a randomized controlled trial","volume":"17","author":"Chama","year":"2013","journal-title":"Afr J Reprod Health"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijgo.2015.06.056","article-title":"Maternal outcomes after 12 hours and 24 hours of magnesium sulfate therapy for eclampsia","volume":"132","author":"Anjum","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"R16-20260916","first-page":"365","article-title":"Comparison of 12 hours versus 24 hours intravenous administration of MgSO4 in the management of eclampsia","volume":"2","author":"Khan","year":"2021","journal-title":"PJMHS"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2165\/00003088-200038040-00002","article-title":"Magnesium sulfate in eclampsia and preeclampsia: pharmacokinetic principles","volume":"38","author":"Lu","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"R18-20260916","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/10641955.2020.1753067","article-title":"Shortened postpartum magnesium sulfate treatment vs traditional 24h for severe preeclampsia: a systematic review and meta-analysis of randomized trials","volume":"39","author":"Yifu","year":"2020","journal-title":"Hypertens Pregnancy"},{"key":"R19-20260916","first-page":"1","article-title":"Duration of postpartum magnesium sulfate for seizure prophylaxis in women with preeclampsia: a systematic review and meta-analysis","volume":"30","author":"Sullivan","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R20-20260916","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ijgo.13082","article-title":"Intravenous magnesium sulfate in the management of severe preeclampsia: a randomized study of 12-hour versus 24-hours maintenance dose","volume":"149","author":"Unwaha","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.ajog.2004.12.056","article-title":"A prospective randomized trial of magnesium sulfate in severe preeclampsia: use of diuresis as a clinical parameter to determine the duration of postpartum therapy","volume":"192","author":"Fontenot","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R23-20260916","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2288-7-5","article-title":"Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data","volume":"7","author":"Friedrich","year":"2007","journal-title":"BMC Med Res Methodol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:02:06Z","timestamp":1789556526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004720"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004720","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"assertion":[{"value":"2021-11-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}